144 related articles for article (PubMed ID: 30346937)
1. MAD2 Combined with Mitotic Spindle Apparatus (MSA) and Anticentromere Antibody (ACA) for Diagnosis of Small Cell Lung Cancer (SCLC).
Wu Y; Tan L; Chen J; Li H; Ying H; Jiang Y; Wu Q; Yu G; Tian Y; Yu J; Zeng T; Yan L; Liu C
Med Sci Monit; 2018 Oct; 24():7541-7547. PubMed ID: 30346937
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of anti-mitotic spindle apparatus antibody (MSA) and anti-centromere antibody (ACA) detected in patients with small cell lung cancer (SCLC).
Tan L; Zhang Y; Jiang Y; Li H; Chen J; Ming F; Wang W; Yu J; Zeng T; Tian Y; Wu Y
Am J Clin Exp Immunol; 2017; 6(2):21-26. PubMed ID: 28337388
[TBL] [Abstract][Full Text] [Related]
3. TRAP1 Shows Clinical Significance in the Early Diagnosis of Small Cell Lung Cancer.
Li X; Li X; Chen S; Wu Y; Liu Y; Hu T; Huang J; Yu J; Pei Z; Zeng T; Tan L
J Inflamm Res; 2021; 14():2507-2514. PubMed ID: 34163209
[TBL] [Abstract][Full Text] [Related]
4. Application of collagen triple helix repeat containing-1 and mitotic spindle apparatus antibody in small cell lung cancer diagnosis.
Liu Y; Hu T; Li X; Li X; Yu J; Wu Y; Chen S; Tan L
J Clin Lab Anal; 2022 May; 36(5):e24412. PubMed ID: 35385156
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies.
Hansen BU; Eriksson S; Lindgren S
Scand J Gastroenterol; 1991 Jul; 26(7):707-13. PubMed ID: 1896812
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation.
Sanoyama I; Sakurai Y; Ichinoe M; Hoshino A; Kesen Y; Kato T; Numata Y; Umezawa A; Jiang SX; Murakumo Y
Pathol Int; 2021 Jan; 71(1):15-23. PubMed ID: 33112501
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
[TBL] [Abstract][Full Text] [Related]
11. SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer.
Kim HR; Lee GO; Choi KH; Kim DK; Ryu JS; Hwang KE; Na KJ; Choi C; Kuh JH; Chung MJ; Lee MK; So HS; Yoon KH; Park MC; Na KS; Kim YS; Park DS
Lung Cancer; 2016 Sep; 99():57-65. PubMed ID: 27565915
[TBL] [Abstract][Full Text] [Related]
12. [Expression of LncRNA AK09398 and Relationship with Prognosis in Patients with Small Cell Lung Cancer].
Liu B; Liu X; Yang Y; Ge J; Li J
Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):754-759. PubMed ID: 27866518
[TBL] [Abstract][Full Text] [Related]
13. MAD2 expression in oral squamous cell carcinoma and its relationship to tumor grade and proliferation.
Rizzardi C; Torelli L; Schneider M; Giudici F; Zandona L; Biasotto M; Di Lenarda R; Melato M
Anticancer Res; 2014 Dec; 34(12):7021-7. PubMed ID: 25503128
[TBL] [Abstract][Full Text] [Related]
14. [DDP-sensitivity-related genes in 10 lung cancer cell lines].
Li CH; Cai L; Chen XS; Meng QW; Sui GJ
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):418-21. PubMed ID: 19024514
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic and Predictive Value of Thyroid Transcription Factor-1, CD56, P40 and Other Clinical Characteristics in Small Cell Lung Cancer Patients].
Wang X; Zhang Y; Hu M; Wang R; Liu L; Qian K; Li Y; Zhi X
Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):522-527. PubMed ID: 28855032
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients.
Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kondo S; Kaji M
Lung Cancer; 2011 Oct; 74(1):124-31. PubMed ID: 21376419
[TBL] [Abstract][Full Text] [Related]
18. Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis.
Yoo SS; Lee JH; Hong MJ; Choi JE; Kang HG; Do SK; Kim JH; Baek SA; Choi SH; Lee WK; Lee YH; Seo H; Lee J; Lee SY; Cha SI; Kim CH; Park JY
Thorac Cancer; 2020 Sep; 11(9):2698-2703. PubMed ID: 32700476
[TBL] [Abstract][Full Text] [Related]
19. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
Zhang X; Dang Y; Li P; Rong M; Chen G
Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
[TBL] [Abstract][Full Text] [Related]
20. Inter-heterogeneity and intra-heterogeneity of α
Kang F; Wang Z; Li G; Wang S; Liu D; Zhang M; Zhao M; Yang W; Wang J
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1520-1528. PubMed ID: 28405726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
